Skip to main content

CORRECTION article

Front. Pharmacol., 04 January 2023
Sec. Ethnopharmacology
Volume 13 - 2022 | https://doi.org/10.3389/fphar.2022.1112418

Corrigendum: Systematic review and meta-analysis of Coptis Chinensis Franch. -containing traditional Chinese medicine as an adjunct therapy to metformin in the treatment of type 2 diabetes mellitus

This article is a correction to:

  1. Systematic review and meta-analysis of Coptis chinensis Franch.-containing traditional Chinese medicine as an adjunct therapy to metformin in the treatment of type 2 diabetes mellitus

    1. Read original article
Linlin PanLinlin PanXin ZhaiXin ZhaiZhanhui DuanZhanhui DuanKun XuKun XuGuirong Liu Guirong Liu*
  • Shandong University of Traditional Chinese Medicine, Jinan, Shandong, China

A Corrigendum on
Systematic review and meta-analysis of Coptis Chinensis Franch.-containing traditional Chinese medicine as an adjunct therapy to metformin in the treatment of type 2 diabetes mellitus

by Pan L, Zhai X, Duan Z, Xu K and Liu G (2022). Front. Pharmacol. 13:956313. doi: 10.3389/fphar.2022.956313

In the published article, there was an error in the Funding statement. Only one funder appeared in the final published article. The correct Funding statement appears below.

Funding

“This work was supported by Qilu Zhiyuan academic school inheritance project (2022-93); Cultivation project of science and technology history of Shandong University of traditional Chinese Medicine (2021KJSKFKT-B03); National Traditional Chinese Medicine Administration Key Discipline Construction Project of Traditional Chinese Medicine National Chinese Medicine Offifice Letter (2012) No. 32”.

We apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: Coptis chinensis Franch., type 2 diabetes mellitus, systematic review, meta-analysis, Chinese medicine

Citation: Pan L, Zhai X, Duan Z, Xu K and Liu G (2023) Corrigendum: Systematic review and meta-analysis of Coptis Chinensis Franch. -containing traditional Chinese medicine as an adjunct therapy to metformin in the treatment of type 2 diabetes mellitus. Front. Pharmacol. 13:1112418. doi: 10.3389/fphar.2022.1112418

Received: 30 November 2022; Accepted: 20 December 2022;
Published: 04 January 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Pan, Zhai, Duan, Xu and Liu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Guirong Liu, 645173627@qq.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.